In minority women, healthy diet reduces risk of type 2 diabetes
the ONA take:
While consuming a healthy diet is associated with a lower risk of type 2 diabetes in women, it has the greatest benefit in women who are Asian, Hispanic or black, according to a recent study published in Diabetes Care.
Researchers led by Jinnie Rhee, MSc, of the Harvard School of Public Health analyzed patient data in women taken from the Nurses’ Health Study (I and II) -- 156,030 were non-Hispanic white, 2,026 Asian, 2,053 Hispanic, and 2,307 black. The women were followed for up to 28 years and were asked to fill out diet questionnaires every four years. They created a dietary diabetes risk reduction score that included components associated with type 2 diabetes risk, with a higher score indicating a healthier overall diet.
They found that there was a protective association between healthy overall diet and type 2 diabetes risk across all racial and ethnic groups. However, since minority women were initially at a higher risk of diabetes than white women, healthy diet was seen to prevent 8 cases for every 1,000 minority women compared to 5.3 for every 1,000 white women.
“As the incidence of type 2 diabetes continues to increase at an alarming rate worldwide, these findings can have global importance for what may be the largest public health threat of this century,” Dr. Rhee said.
It has the greatest benefit in women who are Asian, Hispanic or black.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|